348 related articles for article (PubMed ID: 23780844)
1. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
2. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
Stock C; Brenner H
Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
[TBL] [Abstract][Full Text] [Related]
3. Increase in screening for colorectal cancer in older Americans: results from a national survey.
Chen X; White MC; Peipins LA; Seeff LC
J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
[TBL] [Abstract][Full Text] [Related]
4. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
6. Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.
Bandi P; Cokkinides V; Smith RA; Jemal A
Cancer; 2012 Oct; 118(20):5092-9. PubMed ID: 22434529
[TBL] [Abstract][Full Text] [Related]
7. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
8. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
Bae N; Park S; Lim S
Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer test use from the 2005 National Health Interview Survey.
Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413
[TBL] [Abstract][Full Text] [Related]
11. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
12. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
13. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
14. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening in Canada: results of a national survey.
Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening mode preferences among US veterans.
Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
[TBL] [Abstract][Full Text] [Related]
18. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
19. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
[TBL] [Abstract][Full Text] [Related]
20. Validation of self-reported history of colorectal cancer screening.
Khoja S; McGregor SE; Hilsden RJ
Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
